Free Trial

Birch Capital Management LLC Buys 20,866 Shares of Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Birch Capital Management LLC increased its position in shares of Genpact Limited (NYSE:G - Free Report) by 22.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,082 shares of the business services provider's stock after purchasing an additional 20,866 shares during the period. Genpact accounts for about 2.5% of Birch Capital Management LLC's investment portfolio, making the stock its 15th largest holding. Birch Capital Management LLC owned 0.06% of Genpact worth $4,900,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its holdings in Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after buying an additional 2,060,595 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Genpact by 34.2% during the second quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider's stock valued at $107,065,000 after acquiring an additional 847,249 shares during the period. Los Angeles Capital Management LLC purchased a new stake in shares of Genpact in the 3rd quarter valued at approximately $19,779,000. Tandem Investment Advisors Inc. purchased a new stake in shares of Genpact in the 3rd quarter valued at approximately $17,025,000. Finally, Geode Capital Management LLC boosted its stake in Genpact by 12.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock worth $148,142,000 after purchasing an additional 413,646 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Jefferies Financial Group increased their price objective on Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a research note on Monday, September 9th. Robert W. Baird increased their price target on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. TD Cowen upped their price objective on shares of Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a research note on Friday, November 8th. Finally, Needham & Company LLC lifted their target price on shares of Genpact from $42.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, November 11th. Eight investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Genpact presently has an average rating of "Hold" and an average target price of $42.33.

View Our Latest Analysis on Genpact

Insider Activity at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In the last ninety days, insiders have sold 23,058 shares of company stock valued at $1,044,715. Corporate insiders own 2.80% of the company's stock.

Genpact Stock Down 1.8 %

NYSE:G traded down $0.80 during trading hours on Tuesday, reaching $42.86. The company's stock had a trading volume of 1,012,298 shares, compared to its average volume of 1,131,274. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The company has a market cap of $7.56 billion, a price-to-earnings ratio of 11.77, a price-to-earnings-growth ratio of 1.54 and a beta of 1.18. Genpact Limited has a one year low of $30.23 and a one year high of $47.98. The business's 50-day moving average is $43.70 and its 200-day moving average is $39.02.

Genpact Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 23rd. Stockholders of record on Monday, December 9th were issued a dividend of $0.1525 per share. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend was Monday, December 9th. Genpact's dividend payout ratio is 16.76%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Analysts boosting their targets. Find out how Oracle’s cloud push is reshaping its business and driving new growth opportunities.

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines